Lisata Therapeutics, Inc. Common Stock (LSTA) is a publicly traded Healthcare sector company. As of November 9, 2026, LSTA trades at $1.04 with a market cap of $11.13M and a P/E ratio of -0.80. LSTA moved +0.97% today. Year to date, LSTA is -47.45%; over the trailing twelve months it is -56.17%. Its 52-week range spans $0.96 to $5.07. Rallies surfaces LSTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Lisata Therapeutics, Inc. Common Stock (LSTA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LSTA moved +0.97% today.
| Metric | Value |
|---|---|
| Price | $1.04 |
| Market Cap | $11.13M |
| P/E Ratio | -0.80 |
| EPS | $-1.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.07 |
| 52-Week Low | $0.96 |
| Volume | 2.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $170.00K |
| Net Income | $-16.59M |
| Gross Margin | 0.00% |
LSTA analyst coverage data. Average price target: $0.00.